RH Managers
Private equityJohannesburg · Seed–Late Stage · 14 people tracked
Investment thesis
RH Managers follows a thesis-driven investment strategy that pairs extensive research with deep industry knowledge and local market experience in healthcare and impact investing across Africa. The firm invests through private equity in healthcare infrastructure aimed at broadening access to quality healthcare for South Africans. It supports companies across all development stages and takes a long-term view, aligning the interests of portfolio company management teams, limited partners, and the firm's professionals. Operating as an integrated private partnership, it commits its full resources to the success of its portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website
Frequently asked questions
- What stage does RH Managers invest at?
- RH Managers invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does RH Managers focus on?
- RH Managers focuses on Healthtech, Impact & Social Good.
- Where is RH Managers located?
- RH Managers is headquartered in Johannesburg, ZA.
Media · Podcasts & interviews
featuring the teamNHI Bill I Quinton Zunga, CEO of RH Managers reacts
SABC News · Quinton Zunga
Images
Similar investors
Partech is a global investment firm that backs founders across multiple continents and at every stage through dedicated teams and funds.
ICONIQ is a global investment firm that manages investment portfolios and client wealth, partnering with technology-focused companies and supporting philanthropic initiatives.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
Future Planet Capital is an impact-led venture capital firm founded in the UK that invests globally in high-growth companies benchmarked against leading universities and centres of innovation.
Cambridge Innovation Capital (CIC) is a UK-based venture capital firm backing entrepreneurs in life sciences and deep tech, leveraging its position in the Cambridge science and technology ecosystem.